← Leaderboards
Gangqing Hu
West Virginia University
$1,277,354
Attributed
$1,277,354
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,277,354 · 2
By mechanism
P20$1,277,354 · 2
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Daniel Flynn$4,466,105
- Marc Kantorow$8,325,279
Others in their field
Other Emerging Leaders on “Hematologic Neoplasms”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Olwen Hahn · Brigham And Women'S Hospital$32,185,622
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Bronwen Shaw · Medical College Of Wisconsin$10,707,191
- Pradeep Natarajan · Massachusetts General Hospital$6,365,733
- Jeremy Lyle Warner · University Of Texas Hlth Sci Ctr Houston$6,096,749
Research focus
Hematologic NeoplasmsLaboratoriesGenesGrowthIn VivoBone MarrowEpigenetic ProcessGene ExpressionGenetic TranscriptionGenomicsBindingB-LymphocytesCellsCell SurvivalDrug ResistanceEngraftmentChromatinEpigenetic RegulationBiological ProcessCoculture TechniquesConditioned Culture MediaGenome-WideCell LineLenalidomide
Grant awards (5)
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma$253,063
P20 · FY2025 · GM · contact PI
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma$259,585
P20 · FY2024 · GM · contact PI
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma$237,781
P20 · FY2023 · GM · contact PI
C/EBPJ3 in bone marrow stromal cell-mediated drug resistance of multiple myeloma$263,733
P20 · FY2022 · GM · contact PI
C/EBPJ3 in bone marrow stromal cell-mediated drug resistance of multiple myeloma$263,192
P20 · FY2021 · GM · contact PI